#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatitis B Phenylketonuria Noonan syndrome Atopic keratoconjunctivitis Primary mediastinal large B-cell lymphoma Warm autoimmune haemolytic anaemia Non-small cell lung cancer recurrent Indolent systemic mastocytosis Primary hyperoxaluria Stargardt's disease Leukocyte adhesion deficiency type I Precursor T-lymphoblastic lymphoma/leukaemia recurrent Muscular dystrophy Neurodegenerative disorder Sexually transmitted disease More trials…

    Learn about Rare Diseases

    MELAS syndrome – Basic Information Glycogen storage disease type II – Life with Disease Loeys-Dietz syndrome – Diagnostics Short-bowel syndrome – Diagnostics Alport’s syndrome – Basic Information Osteosarcoma – Trials in Disease Ocular melanoma – Treatment Congenital hypotransferrinaemia – Trials in Disease Richter’s syndrome – Trials in Disease Medulloblastoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Jnj-81241459 Capivasertib Ivonescimab Censavudine Iti-1284 ABIRATERONE DECANOATE Rezvilutamide ANX007 Oxybuprocaine Hydrochloride Albumin Olea Europaea Pollen Extract Cefepime Sonidegib [89Zr]Bms-986279 XYLOMETAZOLINE HYDROCHLORIDE MB-001 Bevacizumab Zirconium Zr-89 Dorzolamide Rimegepant Tinzaparin Sodium More therapies…

    Learn about Your Condition

    Hydrocele Systemic mastocytosis Papulopustular rosacea Injury Antithrombin III deficiency Pericarditis Tendon disorder Ischaemic skin ulcer Nasopharyngeal cancer Dementia with Lewy bodies Mucopolysaccharidosis I Peripheral artery thrombosis Retinopathy of prematurity Lymphangioma Infertility More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Vitamin D and Oral Iron for Patients with Chronic Heart Failure and Iron Deficiency

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure congestive
    • Cardiac failure chronic
    • Iron deficiency
    Investigated Drugs:
    • Ferric Carboxymaltose
    • Colecalciferol
    Italy

  • Study on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Upadacitinib
    • Vedolizumab
    Austria Belgium Croatia Czechia Denmark France +12

  • Study of oxytocin, dinoprostone, and misoprostol combination for active management in pregnant women with premature rupture of membranes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Preterm premature rupture of membranes
    Investigated Drugs:
    • Mifepristone
    • Dinoprostone
    Italy

  • Study of Vemurafenib and Rituximab for Untreated Hairy Cell Leukemia Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hairy cell leukaemia
    Investigated Drugs:
    • Vemurafenib
    • Cladribine
    • Rituximab
    Italy

  • Study on the Effect of Metyrapone on Heart Health in Patients with Adrenal Tumors and Mild Cushing’s Syndrome

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Metyrapone
    Italy

  • Study of drug combination therapy for patients with recurrent and primary refractory Ewing Sarcoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma recurrent
    • Extra-osseous Ewing’s sarcoma
    • Extra-osseous Ewing’s sarcoma metastatic
    Investigated Drugs:
    • Etoposide Phosphate
    • Anhydrous Docetaxel
    • Ifosfamide
    Austria Belgium Czechia Denmark Finland France +4

  • Study on the Long-Term Effects of Gadoxetic Acid, Gadoteridol, and Gadobenate Dimeglumine on Motor and Cognitive Functions in Healthy Adults

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    Investigated Drugs:
    • Gadobenate Dimeglumine
    • Gadobutrol
    • Gadoteric Acid
    France Germany Italy

  • Study on the Effectiveness of Gilteritinib and Drug Combination for Patients with Relapsed or Refractory Acute Myeloid Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Amsacrine
    • Gilteritinib
    • Idarubicin Hydrochloride
    Czechia Germany Italy Lithuania Portugal Romania +1

  • Study of Nivolumab for Early Stage Hodgkin Lymphoma in Patients with Good Prognosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Nivolumab
    Italy Poland Spain

  • Long-Term Safety Study of Berotralstat for Patients with Hereditary Angioedema from Previous Trials

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hereditary angioedema
    Investigated Drugs:
    • Berotralstat
    Czechia France Germany Italy Poland Slovakia +1
Previous Page
1 … 8 9 10 11 12 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!